International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Pediatric tumors include solid tumors of soft tissue, bone, hematologic malignancies, central nervous system tumors, and other organ systems. Thankfully, in children, most of the lesions are benign; untreated, they also can cause serious medical issues. Thanks to the collaborative efforts of surgeons, pediatric oncologists, and radiation oncologists, the cure rates for pediatric tumors have significantly improved over the last 30 years. In the past, tumors were cured using extensive surgical resection. However, with the discovery of effective chemotherapeutic agents, pediatric oncologists, surgeons, and radiation oncologists formed cooperative groups, and their adopted approach resulted in rapid improvements in cure rates. This progress would not have been possible without standardized and optimal therapy applied to the next generation of protocols, benefiting numerous children and paving the way for more effective tumor treatments. Pediatric surgeons play an important role in the surgical treatment of tumors and often represent the first point of contact. As part of a multidisciplinary team, they deliver a diagnosis and develop a follow-up and treatment plan. Familiarity with common tumors will ensure evidence-based practices are followed, including important principles such as organ preservation and intensified surveillance plans. This special issue encompasses the multidisciplinary approach to pediatric tumor treatment, including, but not limited to, the role of pediatric surgeons, pediatric oncologists, and radiation oncologists in the diagnosis, treatment, and follow-up care of pediatric tumors.
Collaborative breakthroughs in precision diagnosis and treatment of nasopharyngeal cancer: Biomarker‑driven screening and endoscopic minimally invasive surgery reshape the new paradigm of early intervention (Review)
Key immune cells in the tumor immune microenvironment of colorectal cancer: Roles and research advances (Review)
Epigenetic mechanisms and therapeutic advances in diffuse midline glioma (Review)
Recapitulating lung cancer metastasis in vitro: Advances in organoid models and challenges in clinical translation (Review)
GPR176 enhances the epithelial‑mesenchymal transition in gastric cancer cells by activating the PI3K/AKT/mTOR signaling pathway
HMBOX1 inhibits hepatocellular carcinoma progression via PTPN1 mediated AKT1 phosphorylation
[Retracted] Prognostic significance of miR‑218 in human hepatocellular carcinoma and its role in cell growth
Tumor microenvironment in bone sarcomas: Implications for immunotherapy and emerging therapeutic vulnerabilities (Review)
Immunotherapy after EGFR‑TKI treatment in advanced non‑small cell lung cancer: Current status and future perspectives (Review)
[Corrigendum] Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells
CDK1 depletion suppresses glioma malignancy through cell cycle pathway regulation: Mechanistic insights from functional and molecular profiling
[Retracted] Downregulated microRNA‑200a promotes EMT and tumor growth through the Wnt/β‑catenin pathway by targeting the E‑cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma
Origin dictates function: The dual roles of exosomes derived from diverse origins in the onset and progression of colorectal cancer (Review)
Quercetin reduces expression of ATP‑binding cassette transporters by regulating the PTEN/PI3K/AKT signaling pathway in breast cancer cells
Tumor‑associated glucocorticoid inhibition by mifepristone reduces polymorphonuclear myeloid‑derived suppressor cells and promotes antitumor immunity in triple‑negative breast cancer‑bearing mice
Mitochondria in T‑cell tumor immunity and tumor therapies targeting mitochondria (Review)
TRIM46 deficiency‑induced DNA damage enhances the sensitivity of cisplatin in non‑small cell lung cancer by regulating the Akt signaling pathway
Advances in isolation and detection technologies and immunotherapy applications of circulating tumor cells (Review)
High RMI1 expression is associated with cancer cell progression and poor prognosis in prostate cancer